Cadila
May 15, 2012 at 15:11 | Source: Moneycontrol.com
May 15, 2012 at 08:57 | Source: CNBC-TV18
May 11, 2012 at 18:09 | Source: Moneycontrol.com
May 10, 2012 at 14:36 | Source: Moneycontrol.com
May 10, 2012 at 09:51 | Source: CNBC-TV18
May 09, 2012 at 09:53 | Source: Moneycontrol.com
Videos »
Photos »
/ 
News across the web »
May 22, 2012 at 19:07 | Source: Economic Times
May 17, 2012 at 08:12 | Source: The Hindu BusinessLine
May 16, 2012 at 11:36 | Source: FirstPost
May 16, 2012 at 02:02 | Source: Economic Times
May 14, 2012 at 12:46 | Source: FirstPost
Interact & exchange stock tips & market info »
Related News »
Nirmal Bang has recommended hold rating on Cadila Healthcare (CHL) with a target price of Rs 831, in its May 11, 2012 research report. "After tepid performance in the 9MFY12 period, CHL’s domestic business has recovered in 4QFY12 and is likely ...
May 15, 2012 at 08:59 | Source: MoneyControl.com
Cadila Healthcare Ltd, a leading pharmaceutical company presents in formulation, active pharmaceutical ingredients, consumer wellness and animal health segments. The company launched 90 new products including over 40 line extensions of which 29 ...
May 16, 2012 at 04:40 | Source: equitybulls.com
Cadila Healthcare (Cadila) reported lower-than-expected numbers for 4QFY2012, except on the sales front. The company's sales for the quarter were mostly in-line at Rs.1,344cr. On the operating front, gross and operating margins reported an ...
May 16, 2012 at 04:40 | Source: equitybulls.com
Law360, New York (May 11, 2012, 12:11 PM ET) -- Drug company Depomed Inc. lodged a patent infringement suit Wednesday in New Jersey in an effort to block plans by Indian drugmaker Cadila Healthcare Ltd. and its U.S. subsidiary to market a generic version ...
May 11, 2012 at 16:06 | Source: site.law360.com
Cadila Healthcare has posted disappointed performance during the year ended March 2011 due to significant rise in interest burden. Its consolidated net profit declined by 8.2 per cent to Rs.653 crore from Rs.711 crore in the previous year. Its EBDITA ...
May 10, 2012 at 10:02 | Source: pharmabiz.com
Dublin - Research and Markets (http://www.researchandmarkets.com/research/rwrbqc/abbott_enters_into) has announced the addition of GlobalData 's new company profile "Abbott Enters into Licensing and Supply Agreement with Zydus Cadila" to their ...
May 17, 2012 at 08:42 | Source: Boston Globe
The outperformers have been Cadila Healthcare Ltd, Glenmark, GlaxoSmithKline and Pfizer. Cadila: The firm continues to show strong traction in acute and chronic segments, which is also reflected in its fourth quarter performance. Notably, respiratory ...
May 23, 2012 at 17:17 | Source: Livemint.com
Drug company Depomed Inc. lodged a patent infringement suit Wednesday in New Jersey in an effort to block plans by Indian drugmaker Cadila Healthcare Ltd. and its U.S. subsidiary to market a generic version of epilepsy medication Gralise.
May 7, 2012 at 23:56 | Source: site.law360.com
Novavax is committed to using its technology platforms to create geographic-specific vaccine solutions and is therefore involved in several international partnerships, including collaborations with Cadila Pharmaceuticals of India and LG Life ...
May 21, 2012 at 16:58 | Source: NASDAQ
As part of efforts to formulate a comprehensive pharma policy, the pharma representatives including Zydus Cadila Chairman and Managing Director Pankaj R Patel and Dr Reddy''s MD and COO Satish Reddy, presented their views to the GOM. Organisation of ...
May 14, 2012 at 13:32 | Source: MSN India